Nationwide Breast Cancer Prevention Trial Resuts

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant

Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.

Vanderbilt-Ingram Cancer Center Research Earns Funding from Lance Armstrong Foundation to Study Effects of Exercise on Curbing Memory Problems Associated with Chemotherapy

Researchers at the Vanderbilt-Ingram Cancer Center are studying whether exercise can help curb memory and cognitive problems experienced by many cancer survivors following chemotherapy.

Vanderbilt-Ingram Cancer Center Researchers Find Ginseng May Improve Breast Cancer Outcomes

Ginseng, one of the most widely used herbs in traditional Chinese medicine, may improve survival and quality of life after a diagnosis of breast cancer, according to a recent study by Vanderbilt-Ingram Cancer Center researchers. The large epidemiological study, led by Xiao-Ou Shu, M.D., Ph.D., was published online recently in the American Journal of Epidemiology.

Vanderbilt-Ingram Cancer Center Receives Funding to Identify Signals for Breast Cancer in the Blood and Women at High-Risk for the Disease

A team of researchers at Vanderbilt-Ingram Cancer Center has been awarded $1.5 million from the Susan G. Komen Breast Cancer Foundation.

Vanderbilt-Ingram Cancer Center Researcher Studies Effects of Cancer Treatment among Children of Survivors

Can the high doses of chemotherapy and radiation that young cancer patients receive cause inherited health problems for their children?

1 5 6 7 8 9